Climb Bio, Inc. ( CLYM) - Key Metrics
CLYM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.18 | -$0.14 | -$0.14 |
| 2026Q1 | $0 | -$0.20 | -$0.21 | -$0.21 |
| 2025Q4 | $0 | -$0.26 | -$0.23 | -$0.23 |
| 2025Q3 | $0 | -$0.19 | -$0.18 | -$0.18 |
| 2025Q2 | $0 | -$0.13 | -$0.16 | -$0.17 |
CLYM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -18.11 |
| 2026Q1 | 0% | -8.56 |
| 2025Q4 | 0% | -3.85 |
| 2025Q3 | 0% | -2.64 |
| 2025Q2 | 0% | -2.38 |
CLYM
Price: $17.02
52 week price:
Earnings Per Share: -0.82 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 937.9 million